End-of-life options for patients with advanced heart failure

Current Heart Failure Reports

Volumn 7, Issue 3, 2010, Pages 140-147

  Goldfinger, Judith Z ^a   Adler, Eric D ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Advance directives; Brain natriuretic peptide; Cardiac resynchronization therapy; Do not resuscitate order; Heart failure; Hospice; ICD deactivation; Implantable cardioverter defibrillator; Inotropic therapy; Palliative care; Ventricular assist device

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; METHYLPHENIDATE; MILRINONE; NITRATE; OPIATE; RANOLAZINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANGINA PECTORIS; BONE PAIN; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; DEPRESSION; DYSPNEA; FATIGUE; HEART ASSIST DEVICE; HEART FAILURE; HOSPICE CARE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVING WILL; MORBIDITY; MORTALITY; PAIN; PALLIATIVE THERAPY; PROGNOSIS; RESUSCITATION; REVIEW; TERMINAL CARE;

CARDIOTONIC AGENTS; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HEART-ASSIST DEVICES; HOSPICE CARE; HUMANS; PALLIATIVE CARE; PROGNOSIS; RESUSCITATION ORDERS; TERMINAL CARE;

EID: 77955984744     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-010-0017-5     Document Type: Review

References (56)

1. SA Hunt WT Abraham MH Chin, et al. 2009 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 e1 e90 10.1016/j.jacc.2008.11.013 19358937 Published erratum appears in J Am Coll Cardiol 2009, 54:2464
2. DB Bekelman EP Havranek DM Becker, et al. 2007 Symptoms, depression, and quality of life in patients with heart failure J Card Fail 13 643 648 10.1016/j.cardfail.2007.05.005 17923356
3. T Rutledge VA Reis SE Linke, et al. 2006 Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes J Am Coll Cardiol 48 1527 1537 10.1016/j.jacc.2006.06.055 17045884
4. JM Teno S Weitzen ML Fennell V Mor 2001 Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J Palliat Med 4 457 464 10.1089/109662101753381593 1:STN:280:DC%2BD38%2FnslGhsQ%3D%3D 11798477
5. KD Aaronson JS Schwartz TM Chen, et al. 1997 Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 2660 2667 1:STN:280:DyaK2szjs1Krug%3D%3D 9193435
6. WC Levy D Mozaffarian DT Linker, et al. 2006 The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 1424 1433 10.1161/CIRCULATIONAHA.105.584102 16534009
7. C Zugck C Kruger R Kell, et al. 2001 Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model Eur J Heart Fail 3 577 585 10.1016/S1388-9842(01)00167-2 1:STN:280:DC%2BD3MrkvVygsA%3D%3D 11595606
8. LP Fried RA Kronmal AB Newman, et al. 1998 Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study JAMA 279 585 592 10.1001/jama.279.8.585 1:STN:280:DyaK1c7ks1WmtQ%3D%3D 9486752
9. LC Walter RJ Brand SR Counsell, et al. 2001 Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization JAMA 285 2987 2994 10.1001/jama.285.23.2987 1:STN:280:DC%2BD3MzntlOhsA%3D%3D 11410097
10. J Koglin S Pehlivanli M Schwaiblmair, et al. 2001 Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 1934 1941 10.1016/S0735-1097(01)01672-2 1:CAS:528:DC%2BD38XisFaltw%3D%3D 11738297
11. D Casarett A Pickard FA Bailey, et al. 2008 Do palliative consultations improve patient outcomes? J Am Geriatr Soc 56 593 599 10.1111/j.1532-5415.2007. 01610.x 18205757
12. IG Finlay IJ Higginson DM Goodwin, et al. 2002 Palliative care in hospital, hospice, at home: results from a systematic review Ann Oncol 13 Suppl 4 257 264 12401699
13. IJ Higginson I Finlay DM Goodwin, et al. 2002 Do hospital-based palliative teams improve care for patients or families at the end of life? J Pain Symptom Manage 23 96 106 10.1016/S0885-3924(01)00406-7 11844629
14. A Hjalmarson S Goldstein B Fagerberg, et al. 2000 Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA 283 1295 1302 10.1001/jama.283.10.1295 1:CAS:528:DC%2BD3cXitVCktbk%3D 10714728
15. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991, 325:293-302.
16. B Pitt F Zannad WJ Remme, et al. 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 709 717 10.1056/NEJM199909023411001 1:CAS:528:DyaK1MXmtVyrurk%3D 10471456
17. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997, 336:525-533.
18. JG Cleland JC Daubert E Erdmann, et al. 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 1539 1549 10.1056/NEJMoa050496 1:CAS:528:DC%2BD2MXjtFGnsLo%3D 15753115
19. ED Adler JZ Goldfinger J Kalman, et al. 2009 Palliative care in the treatment of advanced heart failure Circulation 120 2597 2606 10.1161/CIRCULATIONAHA.109.869123 20026792
20. Faris R, Flather MD, Purcell H, et al.: Diuretics for heart failure. Cochrane Database Syst Rev 2006, (1):CD003838.
21. MR Costanzo ME Guglin MT Saltzberg, et al. 2007 Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 49 675 683 10.1016/j.jacc.2006.07.073 1:CAS:528:DC%2BD2sXhs1Slt7g%3D 17291932 Published erratum appears in J Am Coll Cardiol 2007, 49:1136
22. DC Currow AP Abernethy 2007 Pharmacological management of dyspnoea Curr Opin Support Palliat Care 1 96 101 10.1097/SPC.0b013e3282ef5e03 18685349
23. AP Sindone AM Keogh PS Macdonald, et al. 1997 Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy Am Heart J 134 889 900 10.1016/S0002-8703(97)80012-9 1:STN:280:DyaK1c%2FlvVynuw%3D%3D 9398101
24. G Cotter E Metzkor E Kaluski, et al. 1998 Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema Lancet 351 389 393 10.1016/S0140-6736(97)08417-1 1:CAS:528:DyaK1cXhtV2qs74%3D 9482291
25. Pittler MH, Guo R, Ernst E: Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev 2008, (1):CD005312.
26. Bausewein C, Booth S, Gysels M, Higginson I: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008, (2):CD005623.
27. S Booth R Wade M Johnson, et al. 2004 The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine Respir Med 98 66 77 10.1016/j.rmed.2003.08.008 14959816 Published erratum appears in Respir Med 2004, 98:476
28. L Radbruch F Strasser F Elsner, et al. 2008 Fatigue in palliative care patients: an EAPC approach Palliat Med 22 13 32 10.1177/0269216307085183 18216074
29. Keteyian SJ, Fleg JL, Brawner CA, Piña IL: Role and benefits of exercise in the management of patients with heart failure. Heart Fail Rev 2010 Jan 26 (Epub ahead of print).
30. JD Harris 2008 Fatigue in chronically ill patients Curr Opin Support Palliat Care 2 180 186 10.1097/SPC.0b013e32830baed0 18685418
31. A Qaseem V Snow P Shekelle, et al. 2008 Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians Ann Intern Med 148 141 146 18195338 This article recommends regular assessments for symptoms that are common at the end of life, including pain, dyspnea, and depression, and provides graded evidence for management
32. TD Fraker Jr SD Fihn 2002 Chronic Stable Angina Writing Committee, et al. 2007 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina J Am Coll Cardiol 50 2264 2274 10.1016/j.jacc.2007.08.002 18061078 Published erratum appears in J Am Coll Cardiol 2007, 50:e1
33. A Strohle 2009 Physical activity, exercise, depression and anxiety disorders J Neural Transm 116 777 784 10.1007/s00702-008-0092-x 18726137
34. Lane DA, Chong AY, Lip GY: Psychological interventions for depression in heart failure. Cochrane Database Syst Rev 2005, (1):CD003329.
35. GA Ewy 1999 Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals? J Am Coll Cardiol 33 572 575 10.1016/S0735-1097(98)00596-8 1:STN:280:DyaK1M7jslehtA%3D%3D 9973041
36. PJ Hauptman P Mikolajczak A George, et al. 2006 Chronic inotropic therapy in end-stage heart failure Am Heart J 152 1096.e1 1096.e8 10.1016/j.ahj.2006. 08.003
37. LW Stevenson 2003 Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy Circulation 108 492 497 10.1161/01.CIR.0000078349.43742.8A 12885733
38. EA Rose AC Gelijns AJ Moskowitz, et al. 2001 Long-term mechanical left ventricular assistance for end-stage heart failure N Engl J Med 345 1435 1443 10.1056/NEJMoa012175 1:STN:280:DC%2BD38%2FmsFGnsQ%3D%3D 11794191
39. MW Rich BL Shore 2003 Dobutamine for patients with end-stage heart failure in a hospice program? J Palliat Med 6 93 97 10.1089/10966210360510190 12710582
40. ER Schockett JM Teno SC Miller B Stuart 2005 Late referral to hospice and bereaved family member perception of quality of end-of-life care J Pain Symptom Manage 30 400 407 10.1016/j.jpainsymman.2005.04.013 16310614
41. B Pyenson S Connor K Fitch B Kinzbrunner 2004 Medicare cost in matched hospice and non-hospice cohorts J Pain Symptom Manage 28 200 210 10.1016/j.jpainsymman.2004.05.003 15336332
42. E Fox K Landrum-McNiff Z Zhong, et al. 1999 Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments JAMA 282 1638 1645 10.1001/jama.282.17.1638 1:STN:280:DC%2BD3c%2FhvFaiug%3D%3D 10553790
43. PJ Hauptman SJ Goodlin M Lopatin, et al. 2007 Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care Arch Intern Med 167 1990 1997 10.1001/archinte.167.18.1990 17923600
44. JL Givens J Tjia C Zhou, et al. 2010 Racial and ethnic differences in hospice use among patients with heart failure Arch Intern Med 170 427 432 10.1001/archinternmed.2009.547 20212178 This article uses Medicare data for more than 98,000 patients and highlights racial disparities in hospice utilization for patients with heart failure, specifically, that black and Latino patients are less likely to enter hospice than white patients
45. RM Wachter JM Luce N Hearst B Lo 1989 Decisions about resuscitation: inequities among patients with different diseases but similar prognoses Ann Intern Med 111 525 532 1:STN:280:DyaL1Mznt1CktA%3D%3D 2549825
46. HM Krumholz RS Phillips MB Hamel, et al. 1998 Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments Circulation 98 648 655 1:STN:280:DyaK1cznvFOitg%3D%3D 9715857
47. LW Stevenson 1998 Rites and responsibility for resuscitation in heart failure: tread gently on the thin places Circulation 98 619 622 1:STN:280:DyaK1cznvFOjug%3D%3D 9715851
48. JL Chen J Sosnov D Lessard RJ Goldberg 2008 Impact of do-not-resuscitation orders on quality of care performance measures in patients hospitalized with acute heart failure Am Heart J 156 78 84 10.1016/j.ahj.2008. 01.030 18585500 This article raises the question of whether do not resuscitate orders prevent patients from receiving appropriate guideline-based heart failure care, including ACE inhibitors
49. AJ Moss WJ Hall DS Cannom, et al. 1996 Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1933 1940 10.1056/NEJM199612263352601 1:STN:280:DyaK2s7hsF2isw%3D%3D 8960472
50. SF Sears Jr JB Conti 2002 Quality of life and psychological functioning of icd patients Heart 87 488 493 10.1136/heart.87.5.488 11997430
51. DB Mark KJ Anstrom JL Sun, et al. 2008 Quality of life with defibrillator therapy or amiodarone in heart failure N Engl J Med 359 999 1008 10.1056/NEJMoa0706719 1:CAS:528:DC%2BD1cXhtVymurnO 18768943 In this study, patients in the ICD group had improved quality of life at 3 and 12 months, but equivalent quality of life at 30 months, as compared to patients in the amiodarone group. However, patients who received a shock from their ICD in the previous month had worse quality of life
52. JE Poole GW Johnson AS Hellkamp, et al. 2008 Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 1009 1017 10.1056/NEJMoa071098 1:CAS:528:DC%2BD1cXhtVymurbN 18768944 In a trial with 829 patients with heart failure who were followed for 45.5 months, receiving a shock was associated with increased mortality, regardless of whether the shock was appropriate. The most common cause of death in the patients who were shocked was progressive heart failure, not sudden cardiac death
53. NE Goldstein R Lampert E Bradley, et al. 2004 Management of implantable cardioverter defibrillators in end-of-life care Ann Intern Med 141 835 838 15583224
54. NE Goldstein D Mehta S Siddiqui, et al. 2008 "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators J Gen Intern Med 23 Suppl 1 7 12 10.1007/s11606-007-0239-8 18095037 This article reported that focus groups of patients with ICDs highlighted patients' anxieties and misconceptions about the devices, as well as the lack of awareness about device deactivation
55. N Goldstein M Carlson E Livote JS Kutner 2010 Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey Ann Intern Med 152 296 299 20194235 The authors surveyed hospices and found that while few had a formal policy in place to address ICD and deactivation, the existence of a formal policy was associated with an increase in device deactivation
56. AE Epstein JP DiMarco KA Ellenbogen, et al. 2008 ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 e1 e62 10.1016/j.jacc.2008.02.032 18498951